Evidence map›Paper›PMID 35106777›Full record

ArticleAlimentary pharmacology & therapeutics2022

Overt hepatic encephalopathy is an independent risk factor for de novo infection in cirrhotic patients with acute decompensation.

Eman Alabsawy, Shalimar, Mohammed Faisal Sheikh, Maria Pilar Ballester, Subrat Kumar Acharya, Banwari Agarwal, Rajiv Jalan

Abstract read
In one paragraph

Article in Alimentary pharmacology & therapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Eman AlabsawyLiver Failure Group, Institute for Liver and Digestive Health, University College London, London, UK.ORCID 0000-0002-0645-4666
ShalimarDepartment of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India.
Mohammed Faisal SheikhLiver Failure Group, Institute for Liver and Digestive Health, University College London, London, UK.
Maria Pilar BallesterDigestive Disease Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.ORCID 0000-0001-7177-5696
Subrat Kumar AcharyaDepartment of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India.
Banwari AgarwalLiver Failure Group, Institute for Liver and Digestive Health, University College London, London, UK.
Rajiv JalanLiver Failure Group, Institute for Liver and Digestive Health, University College London, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe occurrence of overt hepatic encephalopathy (OHE) is associated with increased mortality. HE is commonly precipitated by infection, but whether HE predisposes to new infection is unclear. This study aimed to test if OHE predisposes to de novo infection during hospitalisation and its association with short-term mortality. AIMS AND

methodsSeven hundred and fifty-nine consecutive patients were identified at two institutions from prospectively maintained clinical databases of cirrhotic patients admitted with acute decompensation (AD). Infection and HE data were collected on the day of admission, and the occurrence of de novo infections was assessed for 28 days after admission. EASL-CLIF organ failure criteria were used to determine the presence of organ failures. Multivariable analysis using the logistic regression model was used to assess predictors of 28-day mortality and de novo infection.

resultsPatients were divided into four groups; no baseline OHE or infection (n = 352); OHE with no baseline Infection (n = 221); no OHE but baseline infection (n = 100) and OHE with baseline infection (n = 86). On multivariate analyses, OHE (OR, 1.532 [95% CI, 1.061-2.300, P = 0.024]), and admission to ITU (OR, 2.303 [95% CI, 1.508-3.517, P < 0.001]) were independent risk factors for de novo infection. 28-day mortality was 25.3%, 60.2%, 55.0% and 72.1% in the 4-groups respectively. Age, INR and creatinine were independently predictive of mortality. The presence of overt HE, infection, coagulation, kidney, circulatory, respiratory and liver failures were significantly associated with higher mortality.

conclusionOHE is an independent risk factor for de novo infection in cirrhotic patients with AD.

Indexed as

Hepatic EncephalopathyHumansLiver CirrhosisLogistic ModelsRisk Factors

Identifiers

PMID35106777
PMCPMC9303427

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.